"Name"	"Genes (tot)"	"Stat (dist.dir.up)"	"p (dist.dir.up)"	"p adj (dist.dir.up)"	"Stat (dist.dir.dn)"	"p (dist.dir.dn)"	"p adj (dist.dir.dn)"	"Stat (non-dir.)"	"p (non-dir.)"	"p adj (non-dir.)"	"Genes (up)"	"Stat (mix.dir.up)"	"p (mix.dir.up)"	"p adj (mix.dir.up)"	"Genes (down)"	"Stat (mix.dir.dn)"	"p (mix.dir.dn)"	"p adj (mix.dir.dn)"
"1"	"p53 signaling pathway"	66	2.7802	0.086029	0.17485	-2.7802	0.91508	1	5.8957	0.0021597	0.0078604	35	6.185	0.0099192	0.030641	31	2.0307	0.079648	0.44892
"2"	"mTOR signaling pathway"	147	1.1778	0.49442	0.70211	-1.1778	0.50874	1	4.7937	0.037234	0.092493	68	5.3449	0.095869	0.21365	79	1.5803	0.18469	0.71399
"3"	"mRNA surveillance pathway"	88	2.2671	0.16976	0.30537	-2.2671	0.83311	1	2.3864	0.28555	0.43912	46	3.8633	0.22025	0.40186	41	0.68623	0.41797	0.93232
"4"	"cGMP-PKG signaling pathway"	162	2.8995	0.10993	0.214	-2.8995	0.8933	1	3.0832	0.2594	0.41215	73	6.187	0.036478	0.094842	89	-1.4436	0.95127	1
"5"	"cAMP signaling pathway"	185	3.5932	0.055959	0.12879	-3.5932	0.94689	1	3.8049	0.16956	0.31219	95	5.2748	0.16779	0.32719	90	0.035822	0.64525	1
"6"	"beta-Alanine metabolism"	31	-1.3165	0.89946	1	1.3165	0.099953	0.87459	3.0042	0.089367	0.19291	12	2.037	0.33973	0.55657	19	2.2185	0.052614	0.37806
"7"	"alpha-Linolenic acid metabolism"	22	0.54688	0.47083	0.68543	-0.54688	0.53076	1	-0.43293	0.74735	0.85011	9	1.3659	0.46087	0.6688	13	-1.6997	0.94114	1
"8"	"Wnt signaling pathway"	139	2.4844	0.18632	0.32948	-2.4844	0.8173	1	3.8534	0.11127	0.22762	65	6.2565	0.032969	0.087918	74	-0.58245	0.82147	1
"9"	"Vitamin digestion and absorption"	23	0.81502	0.42235	0.62357	-0.81502	0.58004	1	1.1635	0.38679	0.54289	10	2.4419	0.21291	0.39477	13	-0.5941	0.74485	1
"10"	"Vitamin B6 metabolism"	8	-1.8056	0.92164	1	1.8056	0.078329	0.79087	1.1742	0.33024	0.48757	3	-0.92711	0.82822	0.92288	5	2.2034	0.041956	0.32746
"11"	"Viral myocarditis"	71	5.1837	0.0011806	0.0040606	-5.1837	0.99893	1	3.5425	0.079936	0.17496	41	5.9789	0.01766	0.051018	30	-1.5399	0.95531	1
"12"	"Viral carcinogenesis"	209	6.3425	0.000278	0.0010877	-6.3425	0.99975	1	5.863	0.012256	0.034773	111	9.3267	0.00098898	0.0043459	98	-1.364	0.95078	1
"13"	"Vasopressin-regulated water reabsorption"	42	0.72318	0.51543	0.71461	-0.72318	0.48648	1	3.9179	0.033325	0.084802	22	3.1205	0.20309	0.38402	20	2.4049	0.031922	0.29435
"14"	"Vascular smooth muscle contraction"	122	3.5208	0.050218	0.11999	-3.5208	0.95136	1	1.6543	0.52642	0.69247	60	4.6683	0.14952	0.30097	62	-2.2718	0.98779	1
"15"	"Valine, leucine and isoleucine degradation"	53	-4.0154	0.99954	1	4.0154	0.0004303	0.022447	0.81098	0.56786	0.7196	9	0.060333	0.74069	0.85972	44	0.86278	0.35576	0.88229
"16"	"Valine, leucine and isoleucine biosynthesis"	3	1.7636	0.11699	0.22328	-1.7636	0.88323	1	0.90548	0.33907	0.49825	2	1.6327	0.23998	0.42543	1	-0.74062	0.72809	1
"17"	"VEGF signaling pathway"	55	7.3782	2.2692e-06	1.3401e-05	-7.0664	0.99999	1	7.5441	6.2615e-05	0.00039197	36	8.6394	5.0247e-05	0.0002958	19	0.94348	0.28054	0.81046
"18"	"Ubiquitin mediated proteolysis"	136	-0.59974	0.88054	1	0.59974	0.11996	0.9291	5.5193	0.012332	0.034773	64	3.5667	0.3653	0.57854	72	4.2228	0.00083631	0.051851
"19"	"Ubiquinone and other terpenoid-quinone biosynthesis"	10	0.23649	0.52999	0.71813	-0.23649	0.47059	1	1.4051	0.28564	0.43912	5	1.0202	0.44878	0.6543	5	0.96682	0.24408	0.79914
"20"	"Tyrosine metabolism"	37	0.79427	0.43961	0.64436	-0.79427	0.56286	1	0.39451	0.66145	0.78126	17	1.4793	0.50912	0.69669	20	-0.82726	0.81409	1
"21"	"Type II diabetes mellitus"	45	1.7623	0.23142	0.37903	-1.7623	0.77277	1	2.9657	0.1273	0.25218	23	3.5457	0.15379	0.3059	22	0.61607	0.41188	0.93232
"22"	"Type I diabetes mellitus"	53	3.6697	0.018368	0.048041	-3.6697	0.9826	1	-0.35087	0.81866	0.89283	32	2.1266	0.50394	0.69571	21	-3.1826	0.99654	1
"23"	"Tuberculosis"	159	10.03	3.624e-10	4.7263e-09	-9.8463	1	1	8.7484	9.0764e-06	6.6068e-05	103	10.94	1.465e-05	0.00011427	56	-0.096324	0.68518	1
"24"	"Tryptophan metabolism"	44	-2.3054	0.97957	1	2.3054	0.020024	0.32679	-0.35243	0.81311	0.88987	16	-1.4955	0.9617	0.98056	28	0.68868	0.37636	0.88387
"25"	"Transcriptional misregulation in cancer"	165	8.052	1.149e-06	7.1929e-06	-8.052	1	1	9.836	4.1544e-07	5.0012e-06	101	10.602	2.3024e-05	0.00016706	64	2.4748	0.05447	0.37806
"26"	"Toxoplasmosis"	106	9.4003	3.4377e-09	3.3625e-08	-8.4488	1	1	9.6213	2.3864e-07	3.2057e-06	70	10.755	9.407e-06	7.7236e-05	36	1.5128	0.1568	0.64812
"27"	"Toll-like receptor signaling pathway"	86	8.3147	1.0757e-07	7.8201e-07	-8.3147	1	1	8.2607	7.3723e-06	5.6281e-05	57	9.3159	4.24e-05	0.00026457	29	1.1648	0.24747	0.79914
"28"	"Tight junction"	160	8.6132	8.6745e-08	6.4646e-07	-8.6132	1	1	8.1775	7.2133e-05	0.0004427	98	10.181	8.5299e-05	0.00047524	62	0.33719	0.54202	0.97222
"29"	"Thyroid hormone synthesis"	72	2.6131	0.094107	0.19004	-2.6131	0.90787	1	1.5414	0.47235	0.63727	42	2.0466	0.59867	0.75964	30	-0.033514	0.65047	1
"30"	"Thyroid hormone signaling pathway"	114	2.8743	0.10038	0.19891	-2.8743	0.90199	1	7.7274	8.6487e-05	0.0005013	58	7.9625	0.0011412	0.0049451	56	2.922	0.024545	0.29435
"31"	"Thyroid cancer"	28	3.0503	0.036154	0.090529	-3.0503	0.96483	1	5.5254	0.0014579	0.0056336	17	5.2263	0.010858	0.033213	11	2.3184	0.028945	0.29435
"32"	"Thiamine metabolism"	13	-2.9519	0.99005	1	2.9519	0.0099348	0.24	2.0507	0.18119	0.32222	5	-0.57011	0.79216	0.89917	8	3.0649	0.0063978	0.14167
"33"	"Th17 cell differentiation"	97	5.0368	0.002791	0.0085646	-5.0368	0.99739	1	6.9584	0.00042787	0.0018862	55	7.737	0.0018403	0.0072679	42	1.7209	0.14422	0.62096
"34"	"Th1 and Th2 cell differentiation"	84	2.893	0.070055	0.15019	-2.893	0.93204	1	4.0301	0.053994	0.12612	46	4.4833	0.1267	0.26531	38	1.0592	0.27831	0.81046
"35"	"Terpenoid backbone biosynthesis"	21	-0.92801	0.80953	0.94545	0.92801	0.19041	1	0.23607	0.61884	0.75076	6	1.3633	0.40501	0.61341	15	-0.5829	0.77595	1
"36"	"Taurine and hypotaurine metabolism"	10	2.2203	0.097455	0.19553	-2.2203	0.90379	1	1.4809	0.26987	0.4248	8	1.4942	0.40992	0.61488	2	0.32302	0.42709	0.93232
"37"	"Taste transduction"	54	-1.0251	0.87822	1	1.0251	0.1217	0.9291	-4.5825	0.99979	1	24	-3.9834	0.99972	1	30	-2.5852	0.99546	1
"38"	"TNF signaling pathway"	105	15.276	0	0	-15.276	1	1	15.921	0	0	77	17.282	2.2204e-16	3.4639e-14	28	2.172	0.06215	0.40139
"39"	"TGF-beta signaling pathway"	80	9.4846	2.4515e-09	2.6137e-08	-9.4846	1	1	5.8666	0.0027694	0.0097255	62	7.5837	0.0033812	0.012411	18	-1.7069	0.94477	1
"40"	"T cell receptor signaling pathway"	100	6.8691	1.0156e-05	5.2979e-05	-6.8691	0.99999	1	7.4574	8.0634e-05	0.00048352	59	9.5016	4.7028e-05	0.00028217	41	0.24844	0.56323	0.98091
"41"	"Systemic lupus erythematosus"	120	2.1764	0.19932	0.34091	-2.1764	0.80311	1	-6.4529	1	1	56	0.9718	0.85276	0.92358	58	-3.7689	0.99985	1
"42"	"Synthesis and degradation of ketone bodies"	9	-1.4703	0.88318	1	1.4703	0.11604	0.9291	-0.62328	0.74962	0.85011	1	-0.027108	0.58325	0.75507	8	-0.6515	0.75849	1
"43"	"Synaptic vesicle cycle"	59	1.0795	0.40232	0.60251	-1.0795	0.59997	1	-0.26672	0.82652	0.89516	32	0.16067	0.87413	0.92819	27	-0.56919	0.78683	1
"44"	"Sulfur relay system"	7	0.27892	0.49555	0.70211	-0.27892	0.50506	1	-0.19726	0.65461	0.77611	3	-0.043577	0.66579	0.81782	4	-0.22321	0.63275	1
"45"	"Sulfur metabolism"	10	-0.99294	0.82256	0.95711	0.99294	0.17688	1	0.98726	0.37937	0.54171	4	0.17643	0.65519	0.81119	6	1.1305	0.20105	0.74198
"46"	"Steroid hormone biosynthesis"	85	5.8616	0.00038019	0.0014691	-5.8616	0.99965	1	-0.60959	0.90313	0.95499	57	2.9298	0.492	0.68681	27	-3.7586	0.99974	1
"47"	"Steroid biosynthesis"	18	2.1699	0.1161	0.22318	-2.1699	0.88521	1	1.9584	0.2309	0.38443	11	2.3189	0.26726	0.46326	7	0.23357	0.49211	0.96349
"48"	"Starch and sucrose metabolism"	32	0.25732	0.60228	0.77898	-0.25732	0.39874	1	2.3727	0.17954	0.32113	12	3.4852	0.10022	0.22175	20	0.30167	0.47361	0.95337
"49"	"Staphylococcus aureus infection"	47	8.4201	1.0993e-07	7.8201e-07	-8.4201	1	1	6.0361	0.0012368	0.0049004	36	7.3506	0.00094399	0.0042075	11	-0.82068	0.7925	1
"50"	"Spliceosome"	127	6.4633	8.7456e-05	0.00036991	-5.5907	0.99921	1	5.3727	0.0093482	0.028135	80	6.72	0.033802	0.089374	46	1.2756	0.22354	0.77863
"51"	"Sphingolipid signaling pathway"	117	7.7548	2.6758e-06	1.551e-05	-7.541	1	1	7.6471	0.00012206	0.00068222	73	9.2782	0.00015457	0.00079058	44	0.519	0.46737	0.95318
"52"	"Sphingolipid metabolism"	44	6.2058	5.7987e-05	0.00025208	-5.8571	0.99986	1	5.0163	0.0074547	0.023569	30	6.323	0.0059139	0.019422	14	-0.36306	0.71162	1
"53"	"Small cell lung cancer"	81	4.6788	0.0042645	0.012592	-4.6788	0.99595	1	7.3213	0.00015747	0.00082682	49	7.3572	0.0027568	0.010363	32	2.5441	0.034965	0.30969
"54"	"Signaling pathways regulating pluripotency of stem cells"	133	5.2396	0.0022382	0.0070763	-5.2396	0.99791	1	2.2086	0.40989	0.5702	81	4.0895	0.33966	0.55657	52	-1.5718	0.95269	1
"55"	"Serotonergic synapse"	122	3.626	0.043223	0.10569	-3.626	0.9582	1	1.6274	0.53317	0.69374	66	3.4596	0.40368	0.61341	56	-1.3538	0.93357	1
"56"	"Selenocompound metabolism"	16	0.45961	0.47852	0.69341	-0.45961	0.52284	1	1.0766	0.38348	0.54262	8	0.88934	0.54375	0.73126	8	0.63314	0.34401	0.87908
"57"	"Salmonella infection"	76	11.698	8.6597e-14	2.7042e-12	-11.667	1	1	13.021	1.1113e-13	8.6962e-12	49	15.086	9.2704e-14	4.8206e-12	27	1.5228	0.16929	0.69054
"58"	"Salivary secretion"	74	0.46077	0.59512	0.77614	-0.46077	0.40682	1	-1.1495	0.94247	0.98004	33	0.26236	0.86346	0.92578	41	-1.7796	0.96827	1
"59"	"SNARE interactions in vesicular transport"	31	-0.32325	0.7172	0.85916	0.32325	0.28273	1	1.4567	0.35189	0.51468	14	0.48413	0.69297	0.82949	17	1.5278	0.13907	0.62096
"60"	"Ribosome biogenesis in eukaryotes"	77	6.3953	9.23e-05	0.0003852	-6.3953	0.99991	1	7.2287	0.0001303	0.00071552	46	9.2125	3.591e-05	0.00023838	31	0.17048	0.54182	0.97222
"61"	"Ribosome"	128	6.9822	1.8215e-05	8.9081e-05	-6.9822	0.99998	1	4.8298	0.024526	0.064566	91	5.5872	0.11369	0.24131	37	0.22105	0.55326	0.97449
"62"	"Riboflavin metabolism"	7	-1.4988	0.89364	1	1.4988	0.10588	0.89567	0.48484	0.4939	0.65919	2	-0.4939	0.7212	0.84338	5	0.88604	0.26579	0.81046
"63"	"Rheumatoid arthritis"	77	8.7108	5.9671e-08	4.6693e-07	-8.7108	1	1	5.5926	0.0046029	0.01566	49	9.3749	3.5631e-05	0.00023838	28	-3.1275	0.99766	1
"64"	"Retrograde endocannabinoid signaling"	133	0.95512	0.55402	0.74106	-0.95512	0.44884	1	0.41322	0.83014	0.89598	65	1.2812	0.84888	0.92358	68	-0.67471	0.8284	1
"65"	"Retinol metabolism"	86	6.2406	9.552e-05	0.00039339	-6.2406	0.99992	1	3.2594	0.12216	0.24511	54	6.0127	0.02914	0.079058	31	-1.0324	0.86061	1
"66"	"Renin-angiotensin system"	27	0.49474	0.52393	0.71778	-0.49474	0.4774	1	-1.9379	0.95873	0.98833	12	-0.44562	0.85846	0.92358	15	-2.2014	0.98639	1
"67"	"Renin secretion"	65	0.74511	0.50201	0.70461	-0.74511	0.50024	1	0.77927	0.62563	0.7531	25	3.8793	0.12918	0.26869	39	-0.78534	0.83924	1
"68"	"Renal cell carcinoma"	63	8.8159	1.4068e-08	1.295e-07	-8.8159	1	1	8.1163	8.0522e-06	6.0008e-05	44	9.75	1.2836e-05	0.00010269	19	-0.057996	0.59279	1
"69"	"Regulation of lipolysis in adipocytes"	52	0.16595	0.6476	0.81385	-0.16596	0.35394	1	0.8602	0.55811	0.71529	23	1.0345	0.66418	0.81782	29	0.23056	0.53034	0.97222
"70"	"Regulation of actin cytoskeleton"	207	14.156	0	0	-14.156	1	1	13.952	4.3188e-14	6.7589e-12	134	17.307	2.2204e-16	3.4639e-14	73	0.045784	0.6502	1
"71"	"Ras signaling pathway"	218	9.1577	2.3968e-08	2.0275e-07	-9.1577	1	1	9.3625	1.7419e-06	1.6522e-05	129	11.916	2.2572e-06	2.4284e-05	89	0.30714	0.56739	0.98262
"72"	"Rap1 signaling pathway"	206	10.858	2.5016e-11	3.915e-10	-10.858	1	1	11.381	1.0265e-08	1.6911e-07	124	14.244	2.293e-09	4.2084e-08	82	0.52235	0.50813	0.97222
"73"	"RNA transport"	161	0.45525	0.71426	0.85916	-0.45525	0.28786	1	5.837	0.009455	0.028185	72	6.0235	0.049309	0.1221	88	3.3218	0.012345	0.18989
"74"	"RNA polymerase"	28	-0.32409	0.70796	0.85888	0.32409	0.29251	1	2.7414	0.11474	0.2332	13	1.9564	0.35773	0.57237	15	1.9241	0.068514	0.41646
"75"	"RNA degradation"	75	0.7255	0.52744	0.71778	-0.7255	0.47442	1	5.1326	0.011682	0.034126	36	4.6857	0.068085	0.16216	39	2.6157	0.029996	0.29435
"76"	"RIG-I-like receptor signaling pathway"	54	3.5212	0.028543	0.072633	-3.5212	0.97211	1	2.8274	0.16214	0.30285	31	4.0357	0.14508	0.29777	23	-0.35298	0.69851	1
"77"	"Pyruvate metabolism"	36	-2.7151	0.99009	1	2.7151	0.0099678	0.24	0.4448	0.63039	0.7531	7	0.46492	0.64181	0.8042	29	0.26717	0.5185	0.97222
"78"	"Pyrimidine metabolism"	100	1.0458	0.4896	0.70211	-0.95218	0.48494	1	7.4516	8.1873e-05	0.00048352	43	7.4024	0.0014133	0.0057265	57	3.4404	0.0057723	0.14167
"79"	"Purine metabolism"	173	-1.9392	0.98406	1	1.9392	0.015897	0.31098	6.9433	0.0015581	0.0059473	63	6.4402	0.021291	0.059844	110	3.8336	0.0038007	0.13091
"80"	"Proximal tubule bicarbonate reclamation"	21	-0.65541	0.75552	0.89236	0.65541	0.24459	1	0.24342	0.6171	0.75076	11	-0.88624	0.88882	0.93686	10	1.2822	0.20039	0.74198
"81"	"Proteoglycans in cancer"	197	13.302	0	0	-13.196	1	1	13.609	7.8415e-13	3.068e-11	119	17.412	2.3315e-15	2.4247e-13	78	0.12077	0.64599	1
"82"	"Protein processing in endoplasmic reticulum"	157	6.8208	3.0607e-05	0.00013884	-5.9561	0.99967	1	7.4893	0.00025986	0.0012513	81	9.9985	3.2238e-05	0.00022352	76	0.44206	0.51957	0.97222
"83"	"Protein export"	25	-0.36841	0.71865	0.85916	0.36841	0.28156	1	-0.63121	0.81284	0.88987	11	-0.7946	0.87852	0.92914	14	-0.13915	0.64328	1
"84"	"Protein digestion and absorption"	85	5.329	0.0013236	0.004503	-5.329	0.99878	1	1.8193	0.42541	0.58917	52	3.975	0.24599	0.43361	33	-2.0699	0.97488	1
"85"	"Proteasome"	45	0.45496	0.56601	0.75069	-0.45496	0.43622	1	0.95304	0.52654	0.69247	19	2.1909	0.36737	0.57889	26	-0.61912	0.77928	1
"86"	"Prostate cancer"	85	5.8143	0.00042677	0.0016094	-5.8143	0.99961	1	5.2094	0.011775	0.034126	51	7.2868	0.0034904	0.012517	34	-0.68762	0.81514	1
"87"	"Propanoate metabolism"	30	-5.5726	0.99997	1	5.5726	2.3682e-05	0.0024708	2.0983	0.22828	0.38443	2	-1.7678	0.91321	0.94658	28	2.6444	0.027046	0.29435
"88"	"Prolactin signaling pathway"	67	4.6531	0.0039519	0.011781	-4.6531	0.99628	1	3.6031	0.07178	0.16163	43	4.4371	0.11048	0.23772	24	0.080916	0.5773	0.99423
"89"	"Progesterone-mediated oocyte maturation"	81	-0.3141	0.78198	0.92015	0.3141	0.21903	1	1.1865	0.59898	0.74103	38	0.65753	0.82059	0.92095	43	1.0103	0.31114	0.83873
"90"	"Prion diseases"	33	8.1712	7.3714e-08	5.6274e-07	-7.2763	1	1	5.471	0.0016804	0.006337	25	6.6439	0.0030807	0.011443	8	-0.63331	0.75359	1
"91"	"Primary immunodeficiency"	34	2.5072	0.081857	0.16746	-2.5072	0.91949	1	1.6445	0.32494	0.48484	23	1.3622	0.59308	0.75964	11	0.92154	0.24514	0.79914
"92"	"Primary bile acid biosynthesis"	15	2.17	0.13066	0.24489	-2.17	0.8708	1	2.0852	0.17532	0.3172	8	3.2675	0.11166	0.23862	7	-0.44073	0.70912	1
"93"	"Porphyrin and chlorophyll metabolism"	40	3.0136	0.049747	0.11977	-3.0136	0.95172	1	1.263	0.44335	0.60334	20	4.346	0.049305	0.1221	19	-0.74295	0.78605	1
"94"	"Platinum drug resistance"	75	1.0243	0.44055	0.64436	-1.0243	0.56155	1	3.7433	0.078159	0.17228	39	2.805	0.39562	0.60804	36	2.4834	0.036301	0.31259
"95"	"Platelet activation"	119	7.1716	1.2445e-05	6.2826e-05	-7.1716	0.99999	1	5.6844	0.0095469	0.02819	77	7.1714	0.013403	0.039827	42	-0.14183	0.68312	1
"96"	"Phototransduction"	25	1.3963	0.26087	0.41239	-1.3963	0.74083	1	-1.1988	0.89273	0.94721	11	1.2796	0.4904	0.68681	14	-2.7363	0.99508	1
"97"	"Phosphonate and phosphinate metabolism"	5	-0.684	0.72192	0.85916	0.684	0.27801	1	0.091923	0.56373	0.71726	2	-0.47613	0.71756	0.84338	3	0.50743	0.37541	0.88387
"98"	"Phospholipase D signaling pathway"	141	7.5889	4.9308e-06	2.6609e-05	-7.3939	0.99999	1	6.5888	0.0022104	0.0079525	78	9.9566	4.3928e-05	0.00026874	63	-1.2217	0.92219	1
"99"	"Phosphatidylinositol signaling system"	94	-0.52626	0.83621	0.96581	0.52626	0.16455	1	3.848	0.064156	0.14765	41	3.2355	0.31171	0.52889	53	2.2789	0.054879	0.37806
"100"	"Phenylalanine, tyrosine and tryptophan biosynthesis"	6	0.10444	0.53821	0.723	-0.10444	0.46186	1	-2.3517	0.95854	0.98833	2	-0.97543	0.81033	0.91603	4	-2.1905	0.97915	1
"101"	"Phenylalanine metabolism"	21	2.5054	0.074405	0.1563	-2.5054	0.92658	1	-0.24067	0.72498	0.83734	12	1.8832	0.37407	0.58648	9	-2.5422	0.9868	1
"102"	"Phagosome"	161	8.8941	4.8259e-08	3.8731e-07	-8.8941	1	1	7.9182	0.00014396	0.00077688	96	10.746	1.9895e-05	0.00014779	65	-0.59717	0.81782	1
"103"	"Pertussis"	71	9.1777	2.5887e-09	2.6137e-08	-9.1777	1	1	9.2869	1.644e-07	2.3389e-06	46	11	2.3384e-07	2.9183e-06	25	0.72933	0.37504	0.88387
"104"	"Peroxisome"	82	-5.8714	1	1	5.8714	1.9584e-06	0.00043337	3.8151	0.076888	0.17068	23	-0.02863	0.84974	0.92358	59	4.5155	0.00050315	0.051851
"105"	"Pentose phosphate pathway"	29	2.214	0.12834	0.24199	-2.214	0.87302	1	0.57961	0.55989	0.71529	18	1.0026	0.63855	0.80334	11	-0.34137	0.65582	1
"106"	"Pentose and glucuronate interconversions"	33	4.3065	0.0048514	0.014191	-4.3065	0.9953	1	1.8423	0.27952	0.43527	18	5.4566	0.0092716	0.029813	14	-1.1646	0.89276	1
"107"	"Pathways in cancer"	382	10.509	4.1625e-10	5.0111e-09	-10.509	1	1	13.589	1.604e-10	4.564e-09	211	16.802	3.5203e-12	1.2204e-10	171	1.646	0.23332	0.78846
"108"	"Parkinson disease"	123	-0.3122	0.83568	0.96581	0.3122	0.16455	1	-2.1285	0.99294	1	62	-2.4332	0.99946	1	61	-0.56947	0.79556	1
"109"	"Pantothenate and CoA biosynthesis"	17	-0.39202	0.72163	0.85916	0.39202	0.27858	1	2.8567	0.089324	0.19291	7	2.51	0.19773	0.38029	10	1.6246	0.13212	0.60233
"110"	"Pancreatic secretion"	93	2.0627	0.20872	0.35505	-2.0627	0.79473	1	-2.858	0.99796	1	44	1.0968	0.79254	0.89917	48	-3.8433	0.99977	1
"111"	"Pancreatic cancer"	63	4.4208	0.0066525	0.018929	-4.4208	0.99374	1	6.3854	0.0006248	0.0026075	36	7.1596	0.0013884	0.0056997	27	1.4866	0.17704	0.70362
"112"	"PPAR signaling pathway"	79	2.16	0.19085	0.3353	-2.16	0.81273	1	5.1068	0.01355	0.037531	45	4.3631	0.14735	0.29852	34	2.7649	0.0248	0.29435
"113"	"PI3K-Akt signaling pathway"	317	12.389	9.5035e-14	2.7042e-12	-12.389	1	1	13.3	1.2557e-11	4.3671e-10	194	15.906	4.9227e-11	1.2799e-09	123	1.3747	0.27284	0.81046
"114"	"Oxytocin signaling pathway"	146	5.3614	0.0023307	0.0072228	-5.3614	0.99778	1	6.0642	0.0054582	0.017983	77	8.408	0.001671	0.006684	68	0.93426	0.35149	0.88229
"115"	"Oxidative phosphorylation"	113	-0.93306	0.90861	1	0.93306	0.091716	0.86991	-1.838	0.98497	1	53	-2.2192	0.99848	1	60	-0.43663	0.77683	1
"116"	"Ovarian steroidogenesis"	52	1.6632	0.24158	0.38777	-1.6632	0.76093	1	0.54653	0.63506	0.7558	25	2.0044	0.48435	0.68681	27	-1.1703	0.90303	1
"117"	"Other types of O-glycan biosynthesis"	21	-0.29217	0.67239	0.83185	0.29217	0.32801	1	-1.4032	0.90621	0.95503	7	1.1075	0.49289	0.68681	13	-0.31924	0.66753	1
"118"	"Other glycan degradation"	15	-2.5874	0.97883	1	2.5874	0.020881	0.32679	0.59398	0.49042	0.65881	4	-1.1044	0.87464	0.92819	11	1.3596	0.14271	0.62096
"119"	"Osteoclast differentiation"	120	11.432	8.3267e-15	3.2578e-13	-11.432	1	1	11.932	3.9805e-10	9.5837e-09	79	13.876	2.1622e-10	4.8186e-09	41	1.1523	0.27525	0.81046
"120"	"Oocyte meiosis"	107	0.58585	0.60833	0.78357	-0.58585	0.39339	1	2.3266	0.32783	0.48631	54	1.6228	0.74386	0.85972	53	1.6678	0.14409	0.62096
"121"	"One carbon pool by folate"	18	-0.087179	0.63318	0.80909	0.087179	0.36709	1	1.8299	0.25531	0.41091	9	0.93458	0.55861	0.74481	9	1.6532	0.1084	0.56811
"122"	"Olfactory transduction"	656	2.1823	0.56594	0.75069	-2.1823	0.4415	1	-16.667	1	1	336	-10.778	1	1	320	-12.82	1	1
"123"	"Nucleotide excision repair"	42	-4.1811	0.9998	1	4.1811	0.00018005	0.014089	5.0919	0.0048906	0.01646	13	1.8212	0.38679	0.59742	29	4.9085	9.8787e-05	0.015312
"124"	"Notch signaling pathway"	48	1.8379	0.19282	0.3353	-1.8379	0.80991	1	2.0627	0.28936	0.44181	24	3.6494	0.1391	0.28741	24	-0.73229	0.80093	1
"125"	"Non-small cell lung cancer"	57	1.7066	0.2443	0.39013	-1.7066	0.76018	1	5.9098	0.0019357	0.007128	30	5.0545	0.037588	0.096678	27	3.2588	0.007949	0.15854
"126"	"Non-homologous end-joining"	11	-2.4219	0.96702	1	2.4219	0.031947	0.38651	1.6614	0.24061	0.39637	2	0.49921	0.49309	0.68681	9	1.6014	0.11654	0.58272
"127"	"Non-alcoholic fatty liver disease (NAFLD)"	139	4.2034	0.018418	0.048041	-4.2034	0.98239	1	4.6221	0.043471	0.10308	82	4.7317	0.20862	0.38976	57	1.5425	0.18394	0.71399
"128"	"Nitrogen metabolism"	16	1.3796	0.24123	0.38777	-1.3796	0.76105	1	0.10292	0.60882	0.74438	10	0.22893	0.70344	0.83768	6	-0.12749	0.58864	1
"129"	"Nicotine addiction"	35	-0.2417	0.72536	0.85999	0.2417	0.27528	1	-2.2684	0.97806	1	15	-1.2613	0.94646	0.96818	20	-1.9085	0.96499	1
"130"	"Nicotinate and nicotinamide metabolism"	32	0.50258	0.53621	0.723	-0.50258	0.46513	1	4.9763	0.0051917	0.017287	16	3.5649	0.10983	0.23772	16	3.4727	0.0028193	0.10925
"131"	"Neurotrophin signaling pathway"	118	5.574	0.0004227	0.0016094	-5.574	0.9996	1	7.6714	0.00011157	0.00063494	71	8.0197	0.0021736	0.0082702	47	2.2986	0.065748	0.40764
"132"	"Neuroactive ligand-receptor interaction"	238	3.0083	0.14851	0.27343	-3.0083	0.85532	1	-2.2482	0.99896	1	120	0.72186	0.97398	0.98887	118	-3.9208	0.99994	1
"133"	"Neomycin, kanamycin and gentamicin biosynthesis"	4	0.8919	0.30061	0.4658	-0.8919	0.69943	1	0.58258	0.43211	0.59582	2	1.2095	0.32668	0.54798	2	-0.3856	0.65879	1
"134"	"Natural killer cell mediated cytotoxicity"	99	5.485	0.00098281	0.0034957	-5.485	0.9991	1	4.5872	0.028309	0.073229	61	5.936	0.041209	0.10453	38	-0.1167	0.65671	1
"135"	"NOD-like receptor signaling pathway"	150	7.9711	1.1069e-06	7.0709e-06	-7.9711	1	1	9.5818	2.5604e-07	3.2057e-06	88	10.931	8.0544e-06	6.9805e-05	62	1.881	0.12225	0.58304
"136"	"NF-kappa B signaling pathway"	93	9.777	3.4691e-10	4.721e-09	-9.777	1	1	10.136	1.8296e-08	2.727e-07	65	10.795	4.1453e-06	3.8039e-05	28	2.0253	0.078375	0.44892
"137"	"N-Glycan biosynthesis"	48	0.20159	0.63331	0.80909	-0.20159	0.36833	1	0.80754	0.58774	0.73584	21	2.0665	0.4438	0.65314	26	0.85006	0.33976	0.87908
"138"	"Mucin type O-glycan biosynthesis"	26	2.9746	0.041669	0.1027	-2.9746	0.9591	1	1.3105	0.38076	0.54171	17	2.1798	0.34072	0.55657	9	-0.76833	0.77617	1
"139"	"Morphine addiction"	87	0.26621	0.66181	0.82243	-0.26621	0.33958	1	-0.054122	0.83868	0.899	40	0.88972	0.81618	0.9193	47	-0.89443	0.86805	1
"140"	"Mitophagy - animal"	61	0.21839	0.64767	0.81385	-0.21839	0.35352	1	6.3879	0.00063871	0.0026305	25	6.3549	0.0050719	0.0172	36	3.0194	0.012863	0.18989
"141"	"Mismatch repair"	21	-6.338	1	1	6.338	2.7691e-06	0.00043337	5.7542	0.00091865	0.0036864	3	0.82795	0.46673	0.67106	18	5.8773	3.7001e-06	0.001147
"142"	"Mineral absorption"	42	2.8709	0.067275	0.14522	-2.8709	0.93494	1	1.5582	0.3716	0.53782	25	2.6436	0.34047	0.55657	17	-0.75667	0.79755	1
"143"	"MicroRNAs in cancer"	139	10.039	3.9279e-10	4.9177e-09	-10.039	1	1	12.009	5.9951e-11	1.8765e-09	88	13.337	5.2993e-09	9.1855e-08	51	2.3061	0.058366	0.38497
"144"	"Metabolism of xenobiotics by cytochrome P450"	63	1.69	0.28652	0.45065	-1.69	0.71683	1	0.17296	0.74839	0.85011	33	1.4947	0.63757	0.80334	29	0.18497	0.54504	0.97222
"145"	"Metabolic pathways"	1265	3.6876	0.41469	0.61809	-3.5962	0.57064	1	11.436	0.0001585	0.00082682	579	13.845	0.0020552	0.0080152	684	3.4421	0.050061	0.3695
"146"	"Melanoma"	67	3.0311	0.060255	0.13568	-3.0311	0.94147	1	4.0846	0.038455	0.094214	36	5.3969	0.027318	0.074766	31	0.18907	0.53582	0.97222
"147"	"Melanogenesis"	96	4.347	0.0057608	0.016542	-4.347	0.99455	1	1.8299	0.43926	0.60302	53	4.8416	0.095598	0.21365	43	-2.6411	0.99355	1
"148"	"Measles"	121	7.0879	1.9218e-05	9.2541e-05	-6.1974	0.99979	1	7.1813	0.00038037	0.001777	72	8.7989	0.00054922	0.0025963	49	0.619	0.4421	0.93232
"149"	"Maturity onset diabetes of the young"	19	2.4739	0.072288	0.15288	-2.4739	0.9286	1	-0.12943	0.68942	0.80519	12	1.0115	0.57961	0.75507	7	-1.5376	0.93043	1
"150"	"Mannose type O-glycan biosynthesis"	22	-1.3831	0.89882	1	1.3831	0.10059	0.87459	0.49258	0.54864	0.70669	6	1.1787	0.44602	0.65333	16	-0.14422	0.61586	1
"151"	"Malaria"	46	11.782	1.0991e-13	2.8669e-12	-11.782	1	1	10.659	1.2394e-09	2.5862e-08	33	13.046	1.7629e-11	5.0004e-10	13	-0.73643	0.78084	1
"152"	"MAPK signaling pathway"	246	12.124	1.7542e-14	6.1006e-13	-11.481	1	1	14.355	9.7922e-14	8.6962e-12	147	16.936	5.4512e-14	3.4015e-12	98	2.8298	0.032283	0.29435
"153"	"Lysosome"	120	-1.6159	0.97468	1	1.6159	0.025311	0.33388	4.2471	0.068323	0.1561	52	2.3823	0.59895	0.75964	68	3.5588	0.0053958	0.14167
"154"	"Lysine degradation"	56	-2.5132	0.98651	1	2.5132	0.013418	0.28	2.3941	0.2393	0.3963	18	1.5882	0.49936	0.69244	38	1.8133	0.11055	0.56811
"155"	"Lysine biosynthesis"	1	1.1318	0.22894	0.37903	-1.1318	0.77121	1	0.65039	0.38486	0.54262	1	0.65039	0.42177	0.62963	0	NA	NA	NA
"156"	"Longevity regulating pathway - multiple species"	60	5.111	0.0017231	0.0057374	-3.8464	0.98204	1	7.5943	4.1589e-05	0.00027119	32	8.7886	6.1391e-05	0.00035471	28	1.7216	0.12183	0.58304
"157"	"Longevity regulating pathway"	88	3.0111	0.07202	0.15288	-3.0111	0.92991	1	4.3512	0.03872	0.094214	50	4.4841	0.14602	0.29777	38	1.4778	0.17342	0.69817
"158"	"Long-term potentiation"	63	2.8973	0.079438	0.16466	-2.8973	0.92277	1	2.5575	0.20432	0.35727	32	4.3002	0.10631	0.23194	31	-0.72309	0.79717	1
"159"	"Long-term depression"	57	2.1007	0.16212	0.29332	-2.1007	0.84191	1	2.4304	0.22709	0.38443	30	3.1169	0.25712	0.45068	27	0.24584	0.54487	0.97222
"160"	"Lipoic acid metabolism"	2	-0.24064	0.58111	0.76424	0.24064	0.41891	1	0.23365	0.51586	0.68416	1	-0.089593	0.59785	0.75964	1	0.42003	0.36001	0.88387
"161"	"Linoleic acid metabolism"	46	3.4055	0.037085	0.092124	-3.4055	0.96378	1	0.61183	0.62868	0.7531	28	2.6443	0.35477	0.57187	18	-2.3199	0.98158	1
"162"	"Leukocyte transendothelial migration"	107	10.017	7.4405e-10	8.6255e-09	-10.017	1	1	9.1666	5.5286e-07	5.967e-06	66	12.524	7.7447e-09	1.2082e-07	41	-1.0819	0.89835	1
"163"	"Leishmaniasis"	64	9.4062	8.453e-10	9.4492e-09	-9.4062	1	1	7.6579	2.5405e-05	0.00016918	46	9.3616	2.4607e-05	0.00017449	18	-0.52564	0.74199	1
"164"	"Legionellosis"	56	12.515	1.3323e-15	5.9571e-14	-11.206	1	1	12.359	3.3973e-13	1.7564e-11	39	14.338	5.2047e-13	2.0298e-11	17	0.71335	0.34424	0.87908
"165"	"Jak-STAT signaling pathway"	133	7.4963	5.1398e-06	2.7267e-05	-7.4963	1	1	7.2098	0.00021414	0.0010639	81	8.6472	0.00074523	0.0033933	52	0.73816	0.40279	0.92492
"166"	"Intestinal immune network for IgA production"	40	4.5597	0.0032021	0.0096371	-4.5597	0.997	1	0.29166	0.68321	0.80092	28	1.9529	0.5066	0.69629	12	-2.4507	0.98674	1
"167"	"Insulin signaling pathway"	136	3.5812	0.047049	0.11416	-3.5812	0.95401	1	5.7813	0.0079275	0.02439	76	5.8417	0.061341	0.14836	60	2.1294	0.08381	0.4609
"168"	"Insulin secretion"	80	0.23359	0.68444	0.84342	-0.23359	0.31734	1	2.3068	0.29411	0.44688	37	2.1402	0.53186	0.72148	43	1.1612	0.26904	0.81046
"169"	"Insulin resistance"	106	4.188	0.015712	0.041677	-4.188	0.98512	1	8.9457	2.0582e-06	1.8948e-05	58	8.9458	0.00013505	0.00071417	48	3.4602	0.006265	0.14167
"170"	"Inositol phosphate metabolism"	69	-0.62253	0.84221	0.96916	0.62253	0.15806	1	3.5398	0.091961	0.19581	33	2.0257	0.5125	0.69826	36	2.9611	0.014516	0.20054
"171"	"Influenza A"	150	10.672	1.7281e-11	2.9227e-10	-9.7877	1	1	10.495	9.8045e-09	1.6911e-07	95	12.488	1.179e-07	1.5994e-06	55	0.91901	0.37234	0.88387
"172"	"Inflammatory mediator regulation of TRP channels"	118	5.3013	0.00084853	0.0031246	-5.3013	0.9992	1	4.5625	0.040956	0.09861	73	5.2925	0.10238	0.22495	45	0.64734	0.41232	0.93232
"173"	"Inflammatory bowel disease (IBD)"	55	7.2985	2.9425e-06	1.6447e-05	-7.2985	1	1	5.329	0.0064893	0.02094	36	7.4721	0.00073369	0.0033933	19	-1.2186	0.88107	1
"174"	"IL-17 signaling pathway"	84	14.944	0	0	-14.944	1	1	12.743	3.928e-13	1.7564e-11	62	15.534	4.6407e-14	3.4015e-12	22	-1.1766	0.89639	1
"175"	"Hypertrophic cardiomyopathy (HCM)"	81	6.0293	0.00019074	0.00076539	-6.0293	0.99982	1	6.6593	0.00071917	0.0029234	40	10.543	1.469e-06	1.6975e-05	40	0.2318	0.53309	0.97222
"176"	"Huntingtons disease"	178	0.82698	0.63828	0.81212	-0.82698	0.36528	1	0.94057	0.7898	0.87352	89	1.3278	0.90512	0.94133	89	0.0023347	0.66594	1
"177"	"Homologous recombination"	37	-3.7839	0.99877	1	3.7839	0.0011576	0.045291	2.5321	0.17827	0.32068	11	0.22832	0.71902	0.84338	26	2.8722	0.020616	0.26629
"178"	"Histidine metabolism"	24	1.3037	0.29583	0.46067	-1.3037	0.70643	1	2.4093	0.14948	0.28529	10	3.8299	0.051443	0.12638	14	-0.082347	0.62507	1
"179"	"Hippo signaling pathway -multiple species"	25	7.0385	2.8156e-06	1.6023e-05	-7.0385	1	1	4.6776	0.0079482	0.02439	21	5.7486	0.0096832	0.030517	4	-1.4777	0.92242	1
"180"	"Hippo signaling pathway"	150	11.281	8.8063e-13	1.8376e-11	-11.281	1	1	9.3784	5.0554e-07	5.6512e-06	101	12.217	2.3121e-07	2.9183e-06	49	-1.1318	0.90856	1
"181"	"Herpes simplex infection"	184	5.582	0.0016761	0.0056411	-5.582	0.99847	1	5.2478	0.027001	0.070428	104	7.4633	0.01606	0.046829	79	0.36941	0.55152	0.97449
"182"	"Hepatitis C"	116	4.4368	0.0078192	0.021852	-4.4368	0.99276	1	4.804	0.034251	0.086455	67	5.6809	0.064226	0.15414	49	0.74856	0.39937	0.92391
"183"	"Hepatitis B"	130	8.9087	2.089e-08	1.8163e-07	-8.9087	1	1	8.9065	1.7832e-05	0.00012403	84	10.538	1.7909e-05	0.00013628	46	0.73221	0.38213	0.89069
"184"	"Hematopoietic cell lineage"	88	11.314	5.9996e-13	1.3413e-11	-11.314	1	1	8.9331	2.5267e-06	2.0812e-05	58	12.363	6.0416e-09	9.921e-08	30	-1.8908	0.97748	1
"185"	"Hedgehog signaling pathway"	43	1.7966	0.21362	0.36142	-1.7966	0.78773	1	3.1746	0.092858	0.19638	24	2.9123	0.25895	0.45135	19	1.5027	0.14991	0.62799
"186"	"HTLV-I infection"	264	8.847	1.2479e-07	8.6796e-07	-8.8061	1	1	9.3407	7.2198e-06	5.6281e-05	148	12.733	5.9322e-07	7.1187e-06	116	-0.2907	0.79144	1
"187"	"HIF-1 signaling pathway"	98	6.931	2.5152e-05	0.0001175	-6.931	0.99998	1	7.0574	0.00054661	0.0023437	61	8.6162	0.00047529	0.002317	37	0.42239	0.48598	0.96349
"188"	"Graft-versus-host disease"	49	5.2656	0.0010832	0.0038094	-5.2656	0.99901	1	0.73389	0.59494	0.73896	32	3.6827	0.18688	0.36215	17	-3.8066	0.99965	1
"189"	"GnRH signaling pathway"	85	5.1772	0.0018474	0.0060234	-5.0449	0.99772	1	6.0362	0.0027965	0.0097255	46	7.8819	0.00075045	0.0033933	39	0.35113	0.5126	0.97222
"190"	"Glyoxylate and dicarboxylate metabolism"	28	-2.3348	0.97408	1	2.3348	0.025601	0.33388	1.3599	0.37407	0.53782	9	0.042395	0.74399	0.85972	19	1.6217	0.12843	0.60233
"191"	"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"	23	-1.7449	0.93992	1	1.7449	0.059569	0.66589	2.3955	0.14913	0.28529	9	0.88138	0.57054	0.75109	14	2.3638	0.038672	0.32401
"192"	"Glycosphingolipid biosynthesis - lacto and neolacto series"	26	3.6386	0.013904	0.037197	-3.6386	0.98646	1	2.9574	0.091145	0.1954	15	4.7675	0.026637	0.073547	11	-1.0205	0.83835	1
"193"	"Glycosphingolipid biosynthesis - globo and isoglobo series"	15	2.8044	0.061318	0.13612	-2.8044	0.93971	1	2.5857	0.10775	0.22336	9	3.5514	0.089594	0.20256	6	-0.26123	0.63192	1
"194"	"Glycosphingolipid biosynthesis - ganglio series"	14	-0.4227	0.70465	0.85819	0.4227	0.29599	1	0.069504	0.62446	0.7531	7	-0.61954	0.84293	0.92358	7	0.71783	0.33375	0.87908
"195"	"Glycosaminoglycan degradation"	18	-1.4856	0.90171	1	1.4856	0.09778	0.87459	0.35084	0.59463	0.73896	7	-0.63271	0.8448	0.92358	11	0.95353	0.23654	0.78846
"196"	"Glycosaminoglycan biosynthesis - keratan sulfate"	12	1.4949	0.19282	0.3353	-1.4949	0.80747	1	2.523	0.10399	0.21699	7	2.4038	0.21571	0.39589	5	1.0643	0.21922	0.77863
"197"	"Glycosaminoglycan biosynthesis - heparan sulfate / heparin"	23	2.3221	0.11008	0.214	-2.3221	0.89221	1	1.48	0.31525	0.47439	14	1.6558	0.4345	0.64248	9	0.30078	0.45176	0.93364
"198"	"Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate"	19	3.6766	0.010028	0.027295	-3.6766	0.99021	1	2.0594	0.19566	0.346	14	2.8221	0.20298	0.38402	5	-0.70783	0.76074	1
"199"	"Glycolysis / Gluconeogenesis"	62	0.78308	0.49574	0.70211	-0.78308	0.50536	1	2.8486	0.15556	0.29509	27	3.1537	0.22611	0.40778	35	1.0215	0.30602	0.83539
"200"	"Glycine, serine and threonine metabolism"	39	1.6116	0.25033	0.39774	-1.6116	0.75276	1	2.4815	0.17328	0.31627	21	2.7342	0.29469	0.50519	18	0.69952	0.36981	0.88387
"201"	"Glycerophospholipid metabolism"	90	1.5977	0.31426	0.48455	-1.5977	0.6894	1	3.1073	0.15808	0.29807	40	4.9213	0.076648	0.1798	50	-0.23289	0.71296	1
"202"	"Glycerolipid metabolism"	56	2.1317	0.17993	0.31998	-2.1317	0.82262	1	2.9627	0.14052	0.2715	22	6.024	0.0050648	0.0172	34	-1.0435	0.88333	1
"203"	"Glutathione metabolism"	55	-0.084349	0.69986	0.85569	0.084349	0.30109	1	0.38415	0.70267	0.81545	25	0.096778	0.85789	0.92358	30	0.43179	0.49254	0.96349
"204"	"Glutamatergic synapse"	110	2.5423	0.14456	0.26774	-2.5423	0.85874	1	0.4131	0.78686	0.87352	63	1.1363	0.86767	0.9271	47	-0.6836	0.82738	1
"205"	"Glucagon signaling pathway"	95	2.3853	0.14956	0.27375	-2.3853	0.85395	1	5.4096	0.0077375	0.024218	46	6.3827	0.011364	0.034422	49	1.3481	0.22333	0.77863
"206"	"Glioma"	62	3.4297	0.026945	0.069131	-3.4297	0.97352	1	4.3566	0.024547	0.064566	36	4.8879	0.053385	0.13013	26	0.97604	0.30343	0.83539
"207"	"Gastric acid secretion"	70	0.50122	0.58979	0.7724	-0.50122	0.41206	1	-0.23138	0.83682	0.899	34	0.47155	0.85542	0.92358	36	-0.78091	0.8034	1
"208"	"Gap junction"	84	5.1818	0.00089431	0.0032549	-5.1818	0.99918	1	3.0527	0.16255	0.30285	53	4.2769	0.16713	0.32719	31	-0.5672	0.75954	1
"209"	"Galactose metabolism"	31	2.2924	0.10041	0.19891	-2.2924	0.90098	1	4.17	0.019167	0.051276	15	5.0471	0.017995	0.051509	16	0.91763	0.27274	0.81046
"210"	"GABAergic synapse"	83	1.474	0.3429	0.52355	-1.474	0.66053	1	-0.44727	0.89125	0.94721	45	0.52217	0.90166	0.94087	38	-1.2293	0.91011	1
"211"	"Fructose and mannose metabolism"	34	-0.044923	0.64168	0.81314	0.044923	0.35886	1	1.7329	0.30512	0.46137	15	1.2514	0.55343	0.74108	19	1.2063	0.2132	0.76852
"212"	"FoxO signaling pathway"	128	5.5123	0.0009572	0.0034437	-5.5123	0.99913	1	8.1648	2.165e-05	0.00014732	79	7.9119	0.0034475	0.012507	49	3.1503	0.011245	0.18348
"213"	"Folate biosynthesis"	12	0.1977	0.51782	0.71461	-0.1977	0.48234	1	1.7575	0.21796	0.37485	4	2.6023	0.15393	0.3059	8	0.31239	0.44981	0.93364
"214"	"Focal adhesion"	196	15.727	0	0	-15.707	1	1	13.935	1.5921e-13	9.9663e-12	133	17.211	4.5997e-13	2.0298e-11	63	-0.42697	0.77467	1
"215"	"Fluid shear stress and atherosclerosis"	138	11.275	5.0075e-12	9.2198e-11	-11.275	1	1	11.283	6.2837e-10	1.4049e-08	92	12.684	2.5396e-08	3.7731e-07	46	1.6044	0.14942	0.62799
"216"	"Ferroptosis"	38	4.6443	0.0030344	0.009221	-4.6442	0.9971	1	5.6462	0.0012756	0.0049909	22	6.7269	0.0013823	0.0056997	16	0.81336	0.30285	0.83539
"217"	"Fc gamma R-mediated phagocytosis"	84	9.6666	1.0605e-10	1.5087e-09	-9.4143	1	1	8.9896	9.2144e-07	9.3036e-06	62	9.6707	3.8543e-05	0.00024541	22	1.3312	0.20762	0.7572
"218"	"Fc epsilon RI signaling pathway"	63	4.9615	0.0021579	0.006892	-4.9615	0.998	1	6.5621	0.00042166	0.0018854	37	7.3619	0.0012388	0.0052232	26	1.4325	0.18886	0.71399
"219"	"Fatty acid metabolism"	51	-2.3619	0.98267	1	2.3619	0.017034	0.31363	3.2255	0.10005	0.21017	18	1.7262	0.4659	0.67106	33	2.735	0.028661	0.29435
"220"	"Fatty acid elongation"	26	-0.027195	0.65004	0.81385	0.027195	0.3504	1	-0.30043	0.75937	0.85599	10	0.95479	0.53897	0.72796	16	-1.1378	0.87201	1
"221"	"Fatty acid degradation"	47	-2.5294	0.98025	1	2.5294	0.019575	0.32679	1.5474	0.39779	0.55584	17	-0.17095	0.85172	0.92358	30	2.0655	0.074695	0.44529
"222"	"Fatty acid biosynthesis"	12	-0.89177	0.79127	0.92759	0.89177	0.20869	1	1.6963	0.22943	0.38443	6	0.045735	0.6939	0.82949	6	2.3532	0.030743	0.29435
"223"	"Fat digestion and absorption"	36	2.2262	0.11622	0.22318	-2.2262	0.88475	1	1.1491	0.4549	0.61638	17	3.8336	0.075829	0.17923	19	-2.0446	0.96808	1
"224"	"Fanconi anemia pathway"	48	-2.3806	0.98769	1	2.3806	0.012167	0.27202	3.0945	0.11625	0.23475	18	0.96533	0.647	0.80746	30	3.1665	0.0081829	0.15854
"225"	"Ether lipid metabolism"	41	1.7482	0.23127	0.37903	-1.7482	0.77133	1	0.8508	0.5779	0.72937	20	2.5974	0.27875	0.48049	21	-1.346	0.89135	1
"226"	"Estrogen signaling pathway"	94	9.19	2.5453e-09	2.6137e-08	-8.0539	1	1	8.6623	1.2497e-06	1.2223e-05	59	10.645	2.4185e-06	2.4342e-05	35	0.37442	0.50606	0.97222
"227"	"ErbB signaling pathway"	84	6.5047	2.2933e-05	0.00010876	-6.3716	0.99997	1	8.6807	2.4045e-06	2.034e-05	53	8.928	7.89e-05	0.00044758	31	2.6156	0.029847	0.29435
"228"	"Epstein-Barr virus infection"	199	8.4294	8.5137e-07	5.6698e-06	-7.735	0.99999	1	10.756	1.0144e-08	1.6911e-07	108	13.863	5.8463e-10	1.216e-08	91	0.8044	0.43135	0.93232
"229"	"Endometrial cancer"	49	2.7505	0.081794	0.16746	-2.7505	0.92041	1	3.9483	0.03883	0.094214	28	4.4317	0.08406	0.19284	21	0.91374	0.28378	0.81046
"230"	"Endocytosis"	267	8.7252	2.4572e-07	1.672e-06	-8.1255	1	1	11.859	1.0031e-08	1.6911e-07	151	13.563	5.5151e-08	7.8214e-07	116	2.5171	0.06513	0.40764
"231"	"Endocrine resistance"	92	5.6654	0.00055814	0.0020798	-5.5382	0.99929	1	6.2651	0.0022497	0.0080016	55	7.2986	0.0040179	0.014085	37	0.98055	0.30721	0.83539
"232"	"Endocrine and other factor-regulated calcium reabsorption"	48	0.5747	0.52597	0.71778	-0.5747	0.47628	1	-0.12534	0.78791	0.87352	21	1.0154	0.68645	0.82949	27	-1.0627	0.88664	1
"233"	"EGFR tyrosine kinase inhibitor resistance"	78	5.0416	0.0018853	0.0060836	-5.0416	0.99824	1	5.6523	0.0055629	0.018137	48	6.5078	0.012239	0.036716	30	0.88218	0.34054	0.87908
"234"	"ECM-receptor interaction"	82	7.6457	1.4969e-06	9.187e-06	-7.6457	1	1	5.5233	0.0069335	0.022145	46	9.2004	3.7012e-05	0.00024058	36	-2.0642	0.97097	1
"235"	"Drug metabolism - other enzymes"	49	4.1154	0.010691	0.028848	-3.9802	0.98716	1	2.9584	0.12567	0.25055	28	5.1399	0.037804	0.096678	20	0.38469	0.44562	0.93339
"236"	"Drug metabolism - cytochrome P450"	64	2.0168	0.19435	0.3354	-2.0168	0.80772	1	-0.56326	0.86757	0.92679	35	0.87283	0.79116	0.89917	28	-0.27596	0.68423	1
"237"	"Dorso-ventral axis formation"	25	2.7057	0.061111	0.13612	-2.7057	0.93993	1	1.3599	0.36348	0.52916	18	1.3245	0.56307	0.745	7	0.44601	0.42091	0.93232
"238"	"Dopaminergic synapse"	125	3.7658	0.032672	0.08247	-3.7658	0.9688	1	3.0248	0.23009	0.38443	74	3.5557	0.42791	0.63576	51	0.45235	0.47716	0.95432
"239"	"Dilated cardiomyopathy"	86	4.2794	0.0092705	0.025453	-4.2794	0.99138	1	4.7824	0.016625	0.04525	39	8.4737	0.00013816	0.00071841	46	-0.052862	0.64257	1
"240"	"DNA replication"	34	-3.9699	0.9989	1	3.9699	0.0010594	0.045291	4.3625	0.015033	0.041276	10	1.6003	0.38578	0.59742	24	4.1595	0.001089	0.056265
"241"	"D-Glutamine and D-glutamate metabolism"	2	0.43264	0.39886	0.60021	-0.43264	0.60154	1	-1.178	0.82191	0.89325	2	-1.178	0.84189	0.92358	0	NA	NA	NA
"242"	"D-Arginine and D-ornithine metabolism"	1	0.013278	0.51826	0.71461	-0.013278	0.48176	1	-2.3046	0.92435	0.9644	1	-2.3046	0.94298	0.96779	0	NA	NA	NA
"243"	"Cytosolic DNA-sensing pathway"	49	6.4103	6.4596e-05	0.00027697	-6.4103	0.99994	1	6.8763	0.00016498	0.00084651	33	7.5065	0.00052296	0.0025102	16	1.2531	0.1871	0.71399
"244"	"Cytokine-cytokine receptor interaction"	234	15.486	0	0	-15.485	1	1	10.634	2.4705e-07	3.2057e-06	154	15.751	1.0178e-11	3.1755e-10	79	-2.7651	0.99735	1
"245"	"Cysteine and methionine metabolism"	45	1.7572	0.2325	0.37903	-1.7572	0.7717	1	1.3021	0.44332	0.60334	24	1.9093	0.47971	0.68656	21	-0.13504	0.60498	1
"246"	"Complement and coagulation cascades"	85	10.665	1.7742e-11	2.9227e-10	-10.665	1	1	7.8802	4.8073e-05	0.00030708	61	10.789	2.3741e-06	2.4342e-05	24	-2.37	0.98438	1
"247"	"Colorectal cancer"	59	4.182	0.0069521	0.019604	-4.182	0.99332	1	6.5684	0.00039112	0.0018003	36	6.4423	0.0052924	0.017755	23	2.4604	0.041609	0.32746
"248"	"Collecting duct acid secretion"	25	-1.4812	0.91114	1	1.4812	0.088493	0.86557	-0.33964	0.76027	0.85599	8	-0.21185	0.76566	0.8815	17	-0.26655	0.66332	1
"249"	"Cocaine addiction"	46	3.111	0.055869	0.12879	-3.111	0.94526	1	2.4985	0.19682	0.3461	30	2.3987	0.40729	0.61389	16	0.95178	0.26322	0.81046
"250"	"Citrate cycle (TCA cycle)"	29	-4.3534	0.99958	1	4.3534	0.00040948	0.022447	1.7037	0.2862	0.43912	3	-0.1449	0.68716	0.82949	26	1.8486	0.11179	0.56811
"251"	"Circadian rhythm"	29	2.6204	0.07912	0.16466	-2.6204	0.92197	1	4.3191	0.012921	0.03611	18	3.8944	0.080102	0.18642	11	2.0312	0.049636	0.3695
"252"	"Circadian entrainment"	94	0.82056	0.51325	0.71461	-0.82056	0.49011	1	1.4216	0.53415	0.69374	46	1.7471	0.68939	0.82949	48	0.27903	0.5457	0.97222
"253"	"Chronic myeloid leukemia"	70	6.7747	4.2028e-05	0.00018793	-6.7747	0.99996	1	7.1491	0.00016916	0.00085397	45	8.3562	0.00025117	0.001264	25	0.7517	0.36802	0.88387
"254"	"Cholinergic synapse"	108	3.4587	0.050993	0.12091	-3.4587	0.95106	1	2.65	0.27008	0.4248	61	3.8054	0.31191	0.52889	47	-0.31813	0.74001	1
"255"	"Choline metabolism in cancer"	96	4.3961	0.0052041	0.015082	-4.3961	0.99509	1	4.3162	0.04269	0.102	54	5.9495	0.031664	0.085164	42	-0.22065	0.70593	1
"256"	"Chemokine signaling pathway"	178	10.818	2.9865e-12	5.8423e-11	-10.818	1	1	7.2931	0.0005734	0.0024253	114	11.32	2.9628e-06	2.8888e-05	63	-1.9343	0.97814	1
"257"	"Chemical carcinogenesis"	90	4.3728	0.0089523	0.024797	-4.3728	0.99152	1	1.0416	0.60474	0.74229	53	3.317	0.35013	0.56896	36	-1.0094	0.85066	1
"258"	"Chagas disease (American trypanosomiasis)"	99	8.8282	3.9957e-08	3.2912e-07	-8.8282	1	1	8.1774	1.2003e-05	8.5384e-05	68	9.3355	0.00011695	0.0006291	31	0.787	0.34596	0.87908
"259"	"Central carbon metabolism in cancer"	61	6.7815	1.1652e-05	5.9788e-05	-6.7815	0.99999	1	6.8317	0.00023518	0.0011502	41	7.5744	0.0011707	0.0050036	20	1.0862	0.23183	0.78846
"260"	"Cell cycle"	119	0.48032	0.66215	0.82243	-0.48032	0.34007	1	4.5377	0.049421	0.11631	63	3.0862	0.48399	0.68681	56	3.3413	0.010494	0.18073
"261"	"Cell adhesion molecules (CAMs)"	147	7.8862	9.7288e-07	6.344e-06	-7.8862	1	1	3.0318	0.25188	0.40848	86	7.5476	0.0075961	0.024687	61	-4.2553	0.99995	1
"262"	"Cardiac muscle contraction"	71	0.91173	0.48207	0.69533	-0.91173	0.52088	1	0.20114	0.77248	0.86661	33	1.7106	0.58769	0.75768	37	0.012789	0.62125	1
"263"	"Carbon metabolism"	111	-1.818	0.97445	1	1.818	0.025533	0.33388	2.7318	0.24315	0.39846	38	2.795	0.37756	0.58899	73	1.352	0.25059	0.80087
"264"	"Carbohydrate digestion and absorption"	42	1.1693	0.38967	0.58921	-1.1693	0.61316	1	0.20805	0.70342	0.81545	23	0.74918	0.72174	0.84338	19	-0.51496	0.72808	1
"265"	"Calcium signaling pathway"	173	1.9365	0.32709	0.50185	-1.7606	0.63353	1	1.9543	0.5442	0.70386	86	2.776	0.69388	0.82949	87	-0.0042608	0.67677	1
"266"	"Caffeine metabolism"	4	1.7379	0.13469	0.25094	-1.7379	0.86536	1	2.0622	0.13194	0.25973	3	1.9783	0.22392	0.40617	1	0.6979	0.27773	0.81046
"267"	"Butanoate metabolism"	25	-2.0378	0.95841	1	2.0378	0.041261	0.47832	0.81863	0.49492	0.65919	5	1.5109	0.33738	0.55657	20	0.15979	0.52168	0.97222
"268"	"Breast cancer"	141	4.1076	0.020904	0.054073	-4.1076	0.98036	1	4.8662	0.037053	0.092493	76	6.8545	0.015484	0.045575	65	-0.24475	0.72981	1
"269"	"Bladder cancer"	37	8.4756	2.051e-08	1.8163e-07	-8.2751	1	1	8.0257	6.4576e-06	5.1826e-05	25	9.8762	1.9188e-06	2.1381e-05	12	-0.16237	0.63124	1
"270"	"Biotin metabolism"	2	-2.1686	0.93636	1	2.1686	0.063303	0.68324	1.498	0.22633	0.38443	0	NA	NA	NA	2	1.498	0.12162	0.58304
"271"	"Biosynthesis of unsaturated fatty acids"	27	-0.15407	0.69643	0.85483	0.15407	0.30402	1	1.9733	0.2563	0.41091	12	1.9356	0.36226	0.57666	15	0.91623	0.27955	0.81046
"272"	"Biosynthesis of amino acids"	73	1.9391	0.22325	0.37367	-1.9391	0.78015	1	2.0823	0.32529	0.48484	34	3.6942	0.19868	0.38029	39	-0.60045	0.79819	1
"273"	"Bile secretion"	68	1.9125	0.22132	0.37243	-1.9125	0.78284	1	0.25725	0.74154	0.85011	39	0.21323	0.89919	0.94087	29	0.14665	0.55735	0.97615
"274"	"Base excision repair"	32	-3.4372	0.99741	1	3.4372	0.0025246	0.0878	2.1814	0.21296	0.36827	8	0.71813	0.5814	0.75507	24	2.1043	0.077482	0.44892
"275"	"Basal transcription factors"	41	-1.9746	0.96744	1	1.9746	0.032106	0.38651	0.47328	0.6666	0.78438	14	0.0051101	0.78168	0.89663	27	0.57954	0.43376	0.93232
"276"	"Basal cell carcinoma"	53	1.4728	0.29302	0.45857	-1.4728	0.71045	1	0.66859	0.60316	0.74229	25	2.7182	0.32469	0.54758	28	-1.6487	0.94634	1
"277"	"Bacterial invasion of epithelial cells"	66	11.241	4.1311e-13	9.9465e-12	-11.241	1	1	11.351	1.7624e-10	4.597e-09	46	13.157	1.2357e-10	2.9656e-09	20	0.6679	0.35295	0.88229
"278"	"B cell receptor signaling pathway"	68	6.196	0.00013168	0.00053528	-6.196	0.99989	1	6.0579	0.0018276	0.00681	43	7.1965	0.0020942	0.0080666	25	0.55289	0.43165	0.93232
"279"	"Axon guidance"	171	6.2813	0.00027445	0.0010874	-6.2813	0.99974	1	9.38	2.3634e-06	2.034e-05	91	10.922	7.0117e-06	6.2505e-05	80	2.0646	0.10303	0.5507
"280"	"Autophagy - other"	30	-2.4385	0.97665	1	2.4385	0.023047	0.33388	1.861	0.27578	0.4316	12	-0.72766	0.89294	0.93803	18	2.9967	0.014879	0.20054
"281"	"Autophagy - animal"	126	0.79387	0.57702	0.76206	-0.79387	0.42545	1	6.1659	0.0036939	0.012705	65	4.4441	0.21383	0.39477	61	4.2742	0.00069115	0.051851
"282"	"Autoimmune thyroid disease"	50	2.9617	0.055527	0.12879	-2.9617	0.94588	1	-1.5768	0.95991	0.98833	29	1.3087	0.67192	0.82212	21	-3.971	0.99957	1
"283"	"Asthma"	19	2.0466	0.12483	0.23679	-2.0466	0.8763	1	-1.5323	0.91315	0.95825	13	-0.32216	0.8238	0.92124	6	-2.2526	0.9782	1
"284"	"Ascorbate and aldarate metabolism"	26	4.8307	0.0011801	0.0040606	-4.8307	0.99887	1	2.3268	0.1738	0.31627	15	5.877	0.0048701	0.016883	10	-0.84981	0.81051	1
"285"	"Arrhythmogenic right ventricular cardiomyopathy (ARVC)"	70	3.1349	0.064355	0.14086	-3.1349	0.93741	1	3.3311	0.1108	0.22762	31	6.8875	0.0038583	0.013679	38	-0.36793	0.73082	1
"286"	"Arginine biosynthesis"	18	0.90428	0.36919	0.56096	-0.90428	0.63207	1	0.62283	0.52967	0.69367	7	2.3231	0.22999	0.4124	11	-1.0565	0.84585	1
"287"	"Arginine and proline metabolism"	47	2.5091	0.10153	0.19987	-2.509	0.90015	1	4.5087	0.018543	0.050035	22	5.6562	0.0093644	0.029813	25	0.87595	0.32991	0.87908
"288"	"Arachidonic acid metabolism"	83	3.1616	0.058326	0.13229	-3.1616	0.94352	1	0.54364	0.72853	0.83834	45	2.3797	0.56353	0.745	38	-1.7862	0.96493	1
"289"	"Apoptosis - multiple species"	30	2.1354	0.15417	0.28056	-2.1354	0.84891	1	4.4922	0.012269	0.034773	18	3.8882	0.080661	0.18642	12	2.3407	0.042253	0.32746
"290"	"Apoptosis"	132	7.8994	1.8898e-06	1.1375e-05	-7.8994	1	1	9.357	7.8275e-07	8.1667e-06	85	9.8864	0.00011564	0.0006291	47	2.3856	0.057079	0.38466
"291"	"Apelin signaling pathway"	136	6.8615	4.5833e-05	0.00020205	-6.6631	0.99993	1	7.3117	0.00036283	0.0017207	81	8.8938	0.00044046	0.0021813	55	0.70453	0.44029	0.93232
"292"	"Antigen processing and presentation"	71	7.2633	3.4155e-06	1.8756e-05	-6.1007	0.9999	1	3.6431	0.070736	0.16044	47	6.008	0.021538	0.06	24	-2.1415	0.97565	1
"293"	"Antifolate resistance"	29	2.7479	0.06709	0.14522	-2.7479	0.93391	1	3.1017	0.072976	0.16315	17	3.1073	0.16247	0.32083	12	1.1233	0.2348	0.78846
"294"	"Amyotrophic lateral sclerosis (ALS)"	50	1.9967	0.17625	0.31524	-1.9967	0.82626	1	2.8942	0.13713	0.26659	27	3.0802	0.23957	0.42543	23	0.92995	0.30607	0.83539
"295"	"Amphetamine addiction"	63	5.0367	0.0018262	0.0060167	-5.0367	0.99831	1	3.6999	0.061435	0.14244	37	5.2942	0.036236	0.094842	26	-0.55628	0.76398	1
"296"	"Amoebiasis"	94	10.009	6.8501e-11	1.021e-09	-10.009	1	1	9.995	1.1318e-08	1.7713e-07	58	12.831	1.116e-09	2.1762e-08	36	-0.13556	0.62933	1
"297"	"Aminoacyl-tRNA biosynthesis"	43	-3.158	0.99515	1	3.158	0.0048154	0.14789	2.0656	0.25731	0.41091	17	-1.6854	0.97619	0.98887	26	4.0193	0.0015145	0.067071
"298"	"Amino sugar and nucleotide sugar metabolism"	48	0.6579	0.50148	0.70461	-0.6579	0.50089	1	2.7185	0.16822	0.31156	20	3.5875	0.11709	0.24684	28	0.52741	0.42771	0.93232
"299"	"Alzheimers disease"	160	-0.54072	0.88863	1	0.54072	0.1127	0.92829	0.65149	0.80509	0.8873	70	0.42617	0.9417	0.96779	90	0.4928	0.49418	0.96349
"300"	"Allograft rejection"	47	3.01	0.054345	0.1279	-3.01	0.94685	1	-1.1026	0.91539	0.95825	28	1.2903	0.65152	0.80986	19	-3.3004	0.99799	1
"301"	"Aldosterone-regulated sodium reabsorption"	36	0.83313	0.42046	0.62357	-0.83313	0.58116	1	-0.27907	0.78567	0.87352	21	-0.50281	0.918	0.9484	15	0.16259	0.53619	0.97222
"302"	"Aldosterone synthesis and secretion"	83	1.9696	0.22767	0.37903	-1.9696	0.77572	1	2.7768	0.21192	0.36827	40	3.8762	0.20489	0.3851	43	0.11938	0.59264	1
"303"	"Alcoholism"	177	3.4845	0.05806	0.13229	-3.4845	0.94416	1	-4.19	0.99994	1	88	2.5535	0.72174	0.84338	83	-3.3414	0.99916	1
"304"	"Alanine, aspartate and glutamate metabolism"	35	0.24873	0.60147	0.77898	-0.24873	0.40045	1	1.5255	0.37459	0.53782	14	2.0154	0.35558	0.57187	21	0.32388	0.46002	0.94442
"305"	"African trypanosomiasis"	32	6.5162	2.706e-05	0.00012456	-6.5162	0.99998	1	4.6746	0.0088443	0.026876	23	6.1772	0.0056435	0.018731	9	-1.0604	0.84131	1
"306"	"Adrenergic signaling in cardiomyocytes"	140	3.2562	0.062824	0.13848	-3.2562	0.93867	1	3.6717	0.13301	0.26019	71	5.486	0.087773	0.19989	68	0.65821	0.4391	0.93232
"307"	"Adipocytokine signaling pathway"	70	2.1399	0.19503	0.3354	-2.1399	0.80788	1	6.777	0.0003985	0.0018077	37	6.1937	0.0098731	0.030641	33	3.3119	0.0090338	0.16473
"308"	"Adherens junction"	70	7.0816	1.7671e-05	8.7793e-05	-7.0816	0.99998	1	8.7875	2.1374e-06	1.9114e-05	45	9.6939	8.7715e-06	7.3965e-05	25	1.6987	0.1308	0.60233
"309"	"Acute myeloid leukemia"	54	4.8946	0.0023295	0.0072228	-4.8946	0.99776	1	4.3212	0.028946	0.074264	35	5.1319	0.043918	0.1105	19	0.31964	0.47092	0.95337
"310"	"AMPK signaling pathway"	121	2.0991	0.23789	0.3858	-2.0991	0.76518	1	7.1135	0.00044306	0.0019261	63	6.4874	0.019903	0.056453	58	3.5133	0.0049898	0.14167
"311"	"AGE-RAGE signaling pathway in diabetic complications"	99	9.2301	8.4802e-09	8.0433e-08	-9.2301	1	1	9.2352	4.6287e-07	5.3658e-06	66	10.55	3.7772e-06	3.5712e-05	33	1.0755	0.28497	0.81046
"312"	"ABC transporters"	44	-3.0352	0.99463	1	3.0352	0.0051975	0.14789	2.1886	0.24705	0.40274	13	0.95438	0.58111	0.75507	31	1.9893	0.084746	0.4609
"313"	"2-Oxocarboxylic acid metabolism"	17	-1.733	0.93214	1	1.733	0.067428	0.7035	0.36064	0.58361	0.73361	3	1.1071	0.40229	0.61341	14	-0.11509	0.63561	1
